Modifying Virtual Reality Analgesia With Low-Dose Pain Medication
NCT01840774
Unknown
The purpose of this study is to determine how pain relief is modified when the investigators combine the Virtual Reality based Snow World game with certain pain medications.
Gender:
ALL
Ages:
Between 18 years and 60 years
Trial Updated:
04/25/2013
Locations: University of Washington, Seattle, Washington
Conditions: Virtual Reality Therapy
Register for Updates
A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters
NCT01065350
Completed
This is a pilot study to compare the hemodynamic changes that occur during induction with a novel drug combination known as ketofol (propofol and ketamine admixture with that of propofol alone (prototypic anesthesia induction agent). Propofol and ketamine are widely used as induction agents and their effects on patient hemodynamics are well known. Some of these drug-induced hemodynamic changes are undesirable and lead to deleterious effects on patient hemodynamics. We seek to investigate the hem... Read More
Gender:
ALL
Ages:
Between 18 years and 60 years
Trial Updated:
03/21/2013
Locations: Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire
Conditions: Blood Pressure
Register for Updates
Neuromodulation to Facilitate the Effect of Ketamine
NCT01816958
Completed
application of external neuromodulation along with ketamine infusion.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/20/2013
Locations: The Neuroscience Center, Deerfield, Illinois
Conditions: Depression, Chronic Pain, Substance Abuse
Register for Updates
Ketamine Pharmacokinetics in Children Having Heart Surgery
NCT00598195
Completed
What are the pharmacokinetics of ketamine in infants and children requiring ketamine for induction of anesthesia for cardiac surgery that requires CPB? Specific Aim 1: To determine the pharmacokinetic parameters of a single intravenous bolus dose of ketamine in infants and children undergoing cardiac surgery with and without CPB (cardio-pulmonary bypass). Specific Aim 2: To describe the disposition of ketamine's primary active metabolite, norketamine,following a single intravenous bolus dose of... Read More
Gender:
ALL
Ages:
Between 1 day and 6 years
Trial Updated:
02/26/2013
Locations: Arkansas Children's Hospital, Little Rock, Arkansas
Conditions: C.Surgical Procedure; Cardiac
Register for Updates
Oral Ketamine for Control of Chronic Pain in Children
NCT01369680
Completed
The study is a maximum tolerated dose finding study for oral, chronic, daily administration of oral ketamine (by mouth) in children with long-term daily pain.
Gender:
ALL
Ages:
Between 8 years and 22 years
Trial Updated:
02/11/2013
Locations: University of Rochester, Rochester, New York
Conditions: Chronic Pain
Register for Updates
Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients
NCT01169025
Withdrawn
Often, patients transported by aeromedical systems do not receive enough medication to control and relieve their pain. The purpose of this study is to determine if pain treatment with intravenous (IV) ketamine is a better way to treat aeromedical patients' pain than the current treatment practices.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/01/2012
Locations: University of Utah Medical Center, Salt Lake City, Utah
Conditions: Trauma, Pain
Register for Updates
Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects
NCT00690170
Completed
This study examines the interactive effects of ketamine and nicotine.
Gender:
ALL
Ages:
Between 18 years and 50 years
Trial Updated:
05/08/2012
Locations: Veterans Administration Hospital, West Haven, Connecticut
Conditions: Healthy Subjects
Register for Updates
Propofol Versus Ketamine for Moderate Procedural Sedation in the Emergency Department (ED)
NCT00997321
Completed
This study is a clinical trial of moderate sedation with propofol versus moderate sedation with ketamine for procedural sedation in the Emergency Department.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/28/2012
Locations: Hennepin County Medical Center, Minneapolis, Minnesota
Conditions: Sedation
Register for Updates
Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients
NCT00492388
Terminated
To assess the safety and efficacy of PMI-150 (Intranasal Ketamine) as an analgesic for the treatment of breakthrough pain in cancer patients.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/10/2012
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts
Conditions: Pain, Cancer
Register for Updates
Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery
NCT00709436
Completed
The purpose of this research study is to evaluate the safety and analgesic efficacy of PMI-150 (intranasal ketamine) compared to placebo in patients with acute post-operative pain following orthopedic trauma, injury, or surgery.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
01/10/2012
Locations: Jefferson Clinic, Birmingham, Alabama +15 locations
Conditions: Pain, Postoperative
Register for Updates
Ketamine Frequency Treatment for Major Depressive Disorder
NCT00646087
Withdrawn
Depression is a wide spread illness. Depression contributes most significantly to national health care costs. While the number and types of treatments used for depression have expanded over the years, even with an increased range of options, the response rate, defined as the number of subjects who have a 50% reduction in depressive symptoms, is estimated to be around 65%. This randomized clinical trial will examine the frequency of treatment with ketamine in patients with treatment-resistant de... Read More
Gender:
ALL
Ages:
Between 30 years and 65 years
Trial Updated:
06/03/2011
Locations: St. Mary's Duluth Clinic Health System, Duluth, Minnesota
Conditions: Treatment Resistant Depression
Register for Updates
Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair
NCT00451724
Completed
The purpose of this study is to compare how well three different doses of ketamine, given as a spray into the nose, help to sedate children and help them tolerate repairs of cuts on their faces.
Gender:
ALL
Ages:
Between 1 year and 7 years
Trial Updated:
07/21/2010
Locations: Hasbro Children's Hospital, Providence, Rhode Island
Conditions: Laceration
Register for Updates